Prudential Stock Quote PUK - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NYSE
Prudential Plc (PUK) Quote

Prudential Plc (PUK)

16.80

0.15

(0.90%)

Closed September 18 4:00PM

Delayed by 15 minutes

17.49

0.69

( 4.11% )

Pre Market: 6:22AM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

17.49

Bid

-

Ask

-

Volume

2,580

0.00 Day's Range 0.00

15.7703 52 Week Range 23.73

Market Cap

Previous Close

16.80

Open

-

Last Trade

Last Trade Time

05:38:06

Financial Volume

-

VWAP

-

Average Volume (3m)

924,439

Shares Outstanding

2,727,798,000

Dividend Yield

2.41%

PE Ratio

10.51

Earnings Per Share (EPS)

0.62

Revenue

12.19B

Net Profit

1.7B

Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these. Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.

Sector

Life Insurance

Industry

Nondepository Credit Instn

Website

www.prudential.co.uk

Headquarters

London, Gbr

Founded

1986

Prudential Plc is listed in the Life Insurance sector of the New York Stock Exchange with ticker PUK. The last closing price for Prudential was $16.80. Over the last year, Prudential shares have traded in a share price range of $ 15.7703 to $ 23.73.

Prudential currently has 2,727,798,000 shares outstanding. The market capitalization of Prudential is $45.83 billion. Prudential has a price to earnings ratio (PE ratio) of 10.51.

FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.255	7.73021250385	16.235	17.49	16.06	1763094	16.5545698	DR
4	-0.04	-0.228180262407	17.53	18.01	15.7703	1197515	16.73474077	DR
12	-1.27	-6.7697228145	18.76	19.3699	15.7703	924439	17.17946713	DR
26	-2.42	-12.1546961326	19.91	21.1	15.7703	909463	18.05455658	DR
52	-5.65	-24.4165946413	23.14	23.73	15.7703	807324	19.49794676	DR
156	-19.37	-52.5501899078	36.86	42.46	15.7703	685011	24.11972729	DR
260	-19.2	-52.3303352412	36.69	44.99	15.68	574682	26.52912859	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DNMRDanimer Scientific Inc	$ 0.3979 (15.94%)	3.71k
MANUManchester United Plc	$ 17.75 (9.91%)	12
BKKTBakkt Holdings Inc	$ 11.94 (8.84%)	1
SMHISEACOR Marine Holdings Inc	$ 10.95 (8.52%)	8
WOLFWolfspeed Inc	$ 8.99 (7.79%)	15.64k
EMPEntergy Mississippi LLC	$ 20.09 (-13.55%)	20
SCSSteelcase Inc	$ 12.99 (-7.94%)	3.45k
EGOEldorado Gold Corp Ltd	$ 16.23 (-4.87%)	500
ANVSAnnovis Bio Inc	$ 7.97 (-4.67%)	1
KUKEKuke Music Holding Limited	$ 0.69 (-4.18%)	95
NIONIO Inc	$ 5.28 (5.18%)	675.89k
BABAAlibaba Group Holding Limited	$ 87.86 (4.07%)	231.34k
PLTRPalantir Technologies Inc	$ 37.30 (2.53%)	227.71k
RIORio Tinto Plc	$ 65.62 (4.31%)	170.6k
XPEVXPeng Inc	$ 9.17 (6.13%)	151.97k

starkd748

starkd748 2 minutes ago

Im a buyer if .0008s hold for another flip so far this trade has gone as exactly as I expected on the chart

TechandBio

TechandBio 5 minutes ago

$BTC Sound money digital gold should see 100-200k next year.
$SMMT went from $1.00-$25.00 better than Keytruda
ICCM icecure the founder of tencent owns over 50% of the shares kills many kinds of cancer by freezing it multiple studies some 5 years out undervalued.
https://www.pr

Smitty5150

Smitty5150 5 minutes ago

Also to your claim: You know nothing more than the next guy. Your right, in once sense. But in another would you argue that I am wrong in thinking the SP would fly with MHRA approval that coincided with NICE approval vs. just MHRA approval alone? I may not know "nothing more" but I do know what inv

Ms Labonte

Ms Labonte 7 minutes ago

I’m rolling $weet$$ got to $moke out em flipper$$$

jackson73

jackson73 8 minutes ago

TBIO 4.30 sweet

jackson73

jackson73 8 minutes ago

Bountiful_Harvest

Bountiful_Harvest 9 minutes ago

Inflation 2.0

https://pbs.twimg.com/media/GX0n3SOakAIJnBB?format=jpg&name=4096x4096

TechandBio

TechandBio 9 minutes ago

non invasive platforms in medical field doing amazing things PLSE ICCM

Princess17

Princess17 10 minutes ago

India took delivery of 47 mil oz

Smitty5150

Smitty5150 10 minutes ago

I have no idea who Fireman is, but my question still has not be answered with a definitive answer that is based on facts ( I dont like speculation) = Why hasn't NW started the evidence package for NICE? Why wasn't this being worked on well before the ASM? Linda Powers stated herself the work has be

Just the facts maam

Just the facts maam 10 minutes ago

Sr Convertible Notes may start getting converted when ANIP trades at or above $96.34 for 20 consecutive days after September 30, 2024. The following is from ANIP's filing.

Generally. Subject to ?Section 5.01(C)(ii), a Note may be Converted only in the following circumstances:

TrendTrade2016

TrendTrade2016 11 minutes ago

NOT MUCH FUN UNLESS YOU OWN IT...GREAT SHORT TRADE COMING UP

TechandBio

TechandBio 11 minutes ago

$SMMT was a dollar ICCM is .69 kills cancers across many indications including breast and lung cancers no side effects no IV no pills a platform that kills cancer by freezing it multiple studies done independently with 5 year data with 97% success rate 5 years out.
https://www.prnewswire.com/

jackson73

jackson73 12 minutes ago

GetSeriousOK

GetSeriousOK 15 minutes ago

An insider, or someone who did some DD.

Here it is straight from the horse's mouth: "The final rule will be issued in early November."
https://www.cms.gov/newsroom/fact-sheets/cy-2025-medicare-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center

100lbStriper

100lbStriper 15 minutes ago

$NLST You can watch the Senate Judiciary Committee hearing today at 10 am ET through this link below. FYI, there is more on the agenda than the two IP bills.

https://www.judiciary.senate.gov/committee-activity/hearings/09/19/2024/executive-business-meeting-1

AGENDA

Invest-in-America

Invest-in-America 15 minutes ago

But, was HE paid?? And YOU were paid, naturally. Well then, GOD BLESS the both of you!!! (And we'll leave it at that.)

jackson73

jackson73 16 minutes ago

TBIO 3.50 ww room to go...

525k floater

Not likely

Not likely 17 minutes ago

And s/h's wanted out and it happened.

Pump a p/r then dump it.

This is static with this scam as everyone knows.

Old school playbook.

Lol with you pumpers always trying to deny the truth with this ruse.

Invest-in-America

Invest-in-America 19 minutes ago

And ZEO just landed on Jupiter, Homeboy!!! (BONKERS!!!)

davidsson10

davidsson10 21 minutes ago

Reasons To Choose Your Recipes Wisely

https://www.cnn.com/2024/09/18/health/mind-diet-cognitive-decline-wellness/index.html

Color, texture, flavor.....

exwannabe

exwannabe 23 minutes ago

Here is the path to biologic equivalence according to LP at the ASM [highlighting below is mine]. What part of no clinical trial is required don't you understand? Please explain where you get your claim that a clinical trial will be required to certify Eden for commercial production.
How do

retireat40

retireat40 23 minutes ago

The reaction so far hasn’t been overwhelming.

wagner

wagner 23 minutes ago

It would be great if intends will not be the only mentioned part of a new story,
still no volume and shortseller in charge.
Financing, loan could everything......

LTListener

LTListener 25 minutes ago

So many irons in the fire for sure.

Short-term (Q4) should be exciting as this is way overdue for an update on the OSA and NIH/gabakine platforms. The ampakine phase 2 SCI getting started is a big deal and I think investors would love to hear expected milestones on this trial and how

Delayed Upgrade Clock